Esperion 2023-09-13 Health moderate FDA
Health · FDA · Recall #FDA-D-1143-2023
Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured… Recall
Issued September 13, 2023 · Esperion
In September 2023, Esperion recalled the Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed dissolution specifications: below specification results at stability 12-month
What you should do
- 1 Stop using Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Esperion to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Esperion
- Category
- Health
- Recall date
- September 13, 2023
- Units affected
- Not reported
- Sold at
- Nationwide USA
- Recall number
- FDA-D-1143-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Esperion has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.